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ABSTRACT
Ovarian cancer is the fifth leading cause of cancer death in women
between the ages of 35 and 74. With 22 thousand new cases and 15 thousand
deaths annually ovarian cancer is among the most deadly cancers with a death
to incidence ratio of 68%. With 70% of cases High Grade Serous Ovarian
Carcinoma (HGSOC) is the most common type of ovarian cancer and causes
90% of ovarian cancer deaths. 80% of patients have reoccurrence within five
years and only 15-30% of patients with recurrent metastatic ovarian cancer
respond to current therapies, chemotherapy and surgery. One reason for the
high reoccurrence rate is thought to be linked to the heterogeneity of tumors:
there is evidence that, among tumor cells, a subpopulation is cancer stem cells
(CSCs). Since CSCs are frequently drug resistant, when the patient undergoes
chemotherapy many of the cells may die but the CSCs are left behind and the
tumors can therefore regrow. CSCs are also more likely to undergo epithelialmesenchymal transition which gives these cells the ability to more readily migrate
and invade through the extracellular matrix, leaving the primary tumor to form
metastases. One key inducer of EMT and therefore possibly of metastasis of
particular interest in this project is SNAI1 (Snail). It is therefore the goal of this
project to understand the growth, makeup and metastatic ability of HGSOC cell
lines to test possible strategies to decrease growth of cancer and prevent
metastasis.
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In this thesis project the phenotype, CSC population make up, and
functionality of various HGSOC cell lines was examined. The cell lines assessed
were A2780, Kuramochi, OVSAHO, COV318, SKOV3 and OVCAR8. A Snail
knockdown OVCAR8 cell line was also assessed as described above and in a
xenograft model. It was determined that the cell lines show varying phenotype
from epithelial like to mesenchymal like morphology and the cell lines have
varying concentrations of cancer stem cells. It was also determined that the CSC
population of the HGSOC cell lines were positive for both epithelial and
mesenchymal markers in the same cells. OVCAR8 stood out as a hybrid line with
both epithelial and mesenchymal characteristics and was therefore chosen for
the Snail knockdown model. In the Snail knockdown we observed that CSC
markers were reduced, however no change between control and knockdown was
seen in the in vitro functional experiments. There was a difference seen between
Snail knockdown and control in the in vivo mouse xenograft model. Snail
knockdown showed a trend for decreasing tumor burden in both primary and
metastatic tumors and showed a significant decrease in growth of metastatic
tumor at day 43. Based on these results Snail may be an important target for
cancer therapy.
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CHAPTER ONE
INTRODUCTION
1.1 Epithelial Mesenchymal Transition

Epithelial-mesenchymal transition (EMT) is the process by which an
epithelial cell becomes mesenchymal and gains the ability to exit the epithelial
layer of cells and invade through the basement membrane layer. EMT can occur
as the result of many cellular pathways including Wnt, Nodal, FGF, BMP, and
Notch pathways1. EMT events normally occur during embryonic development.
These developmental events that utilize EMT include embryo implantation,
gastrulation, and neural crest formation2.

Figure 1. Overview of epithelial mesenchymal transition 2.

In cancer, EMT events lead to an invasive and metastatic phenotype
allowing cells to leave the primary tumor and invade secondary sites forming
metastasis2. EMT can be observed through changes in transcription factors and
1

proteins involved in EMT pathways. Some of the factors important in this process
are Snail (Snai1), E-cadherin, and N-cadherin. Snail and other transcription
factors are one controlling step in EMT. Snail has the ability to repress the
transcription of E-cadherin, an adherens junction protein important for epithelial
phenotype, and other epithelial proteins3. With this loss of E-cadherin there is a
switch to N-cadherin production in the mesenchymal phenotype 4. Not only is
Snail involved in the EMT process it has also been linked to the development of
chemoresistance in cancer linked to an increase in stemness 5,6.
1.2 Epithelial Ovarian Cancer
Ovarian cancer is the fifth leading cause of cancer death in women 7. With
22,000 new cases and 15,000 deaths annually in the US, ovarian cancer has the
highest death to incidence ratio of any gynecologic cancer8. Epithelial ovarian
cancer (EOC) develops in the epithelial layer of the ovary and most patients are
diagnosed in late stages. About three quarters of ovarian cancer patients present
with stage III or IV tumors9, which means the diseased cells are in a highly
aggressive state and have metastasized within the peritoneal cavity either by
direct extension from the ovary or through the seeding of the cavity by the
production of ascites10. With 70% of cases, High Grade Serous Ovarian
Carcinoma (HGSOC) is the most common type of ovarian cancer and causes 9
out of 10 of ovarian cancer deaths. About 70% of epithelial ovarian cancer
patients experience relapse11 and only 15-30% of patients with recurrent
2

metastatic ovarian cancer respond to current therapies of chemotherapy and
tumor debulking surgery12.
1.3 Cancer Stem Cells
Tumors are a heterogeneous mixture of cell types13. Cancer Stem Cells
(CSCs), also known as tumor initiating (TI) cells, are one of these cell types.
CSCs are thought to be more readily able to leave a primary tumor and invade a
secondary site (undergo metastasis). Circulating tumor cells (CTCs) in patients
have been identified in many cancers to have CSC and EMT markers 14; this has
not yet been reported in ovarian cancer. CSCs are also believed to play a role in
drug resistance in cancer due to the fact that after chemotherapy many cancers
return15. This role of chemoresistance of CSCs has been confirmed in ovarian
cancer16,17. Like normal stem cells CSCs possess self-renewal capacity shown
by the ability of isolated CSC populations to recapitulate the cancer tumor
phenotype in vivo16. Because of this ability combined with the ability of CSCs to
evade traditional cancer therapies, relapse occurs if CSCs are left behind after
treatment.

3

Figure 2. Overview of cancer stem cell theory leading to cancer relapse 18.

Cancer Stem cell make up of a population can be determined by looking
at the presence of ribonucleic acids (RNAs) that mark pluripotency such as
Nanog, Lin28, and Oct419. The presence of these stem cell markers are
indicative of pluripotency, as opposed to multipotency as might be predicted for
tissue stem cells. Lin28 has been shown to be highly expressed in some brain
tumors, and knockdown of Lin28 in these tumors decreased the expression of
Nanog and Oct420, therefore the expression of these pluripotency related RNAs
is very important in assessing a stem cell phenotype. There is some controversy
as to which markers best define ovarian CSC populations 13. There is also some
debate on what constitutes a progenitor cancer cell versus a CSC; it was
therefore important for this study to access many of these markers and have a
strict definition of what was identified as a CSC population. Ovarian CSC
4

populations can also be identified in a cell population through the use of Flow
Cytometry for known ovarian CSC markers CD44, CD133, CD117 (c-kit), and
Aldehyde Dehydrogenase I.13,21 Cancer cell lines with larger populations of
cancer stem cells should be more readily metastatic. Cells with more metastatic
ability have more activity in functional assays such as the scratch assay for
motility analysis and the soft agar assay for anchorage independent growth
ability.
1.4 The Importance of the Let-7 and Snail Interaction
Snail, which is known to cause EMT by repressing E-cadherin and other
epithelial gene expression, has been shown to inhibit the microRNA Let-7 22. Let7 promotes differentiation and inhibits self-renewal via its targets including
HMGA2, LIN28, IMP-1, CDC34, and many others

23

. Let-7 is also seen as a

tumor suppressor due to its repression of targets such as c-Myc and Ras

24

.

Because of this relationship between Let-7 and Snail, Let-7 and pluripotency, and
the involvement of Snail in the EMT process, Snail could be a very important
target in cancer research.
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Figure 3. Schematic representation of the Snail/Let-7 and Snail/cadherin
interactions. Snail up-regulation leads to Let-7 down regulation and increased
stemness of cells. Figure adapted from Unternaehrer et.al.22

1.5 Working Hypothesis
Because Snail is involved in promotion of EMT and in Let-7 inhibition, if
we inhibit Snail we can inhibit EMT and metastasis, and promote tumor
suppression. We should therefore see a shift in EMT status, CSC makeup, and
metastatic potential with knockdown of Snail.

6

Figure 4.. Schematic representation of the hypothesis.

Aim 1: Characterization
ation of epithelial ovarian cancer cell lines for
Epithelial
ithelial Mesenchymal Transition status, Cancer Stem Cell
makeup, and metastatic potential
Epithelial ovarian cancer cell lines A2780, Kuramochi, OVSAHO,
COV318, SKOV3, and OVCAR8 were analyzed by qPCR at the level of RNA for
EMT and CSC markers. EOC cell lines were analyzed with flow cytometry for
EMT and CSC markers. Finally, EOC cell lines were analyzed with Scratch and
Soft-agar
agar assays to determine the relative metastatic potential of the lines.
Aim 2: Characterization
ation of Snail inhibition model of epithelial
ovarian cancer for Epithelial Mesenchymal Transition status,
Cancer Stem Cell makeu
makeup, and metastatic potential
Epithelial ovarian cancer cell line OVCAR8 Snail knockdown and control
cell lines were analyzed with qPCR at the level of RNA for EMT and CSC
markers. Knockdown and control cell lines were analyzed with flow cytometry for
EMT and CSC markers. Knockdown and control cell lines were then analyzed
7

with scratch and soft-agar assays to determine the relative metastatic potential of
the lines. Finally, knockdown and control cell lines are used in a xenograft model
to determine in vivo primary and metastatic growth.
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CHAPTER TWO
MATERIALS AND METHODS
2.1 Cell Culture – In vitro Assays

2.1.1 Ovarian Cancer Cell Culture

Human High Grade Serous Ovarian Carcinoma cell lines were used for all
experiments. The cell lines used were A2780, Kuramochi, OVSAHO, COV318,
SKOV3, and OVCAR8. A fibroblast line, D2F, was also used as a control in some
experiments. A2780, OVSAHO, SKOV3, OVCAR8 and D2F cells were cultured
in Dulbecco's Modification of Eagle's Medium (DMEM) with 10% fetal bovine
serum (FBS), 1% penicillin-streptomycin (PS), and 1% L-Glutamine (L-Glut).
COV318 cells were cultured in DMEM with 10%FBS, 1% PS, 1% L-Glut, and 1%
antibiotic-antimycotic (anti-anti). Kuramochi were cultured in Roswell Park
Memorial Institute Medium (RPMI) with 10% FBS, 1% anti-anti, 1% L-Glut,
human insulin 0.25U/ml, and 1x MEM non-essential amino acids (NEAA). Images
were taken of each cell line with a bright field microscope with phase contrast to
assess general morphology of the cell lines.
2.1.2 Motility
To access motility of cell lines, a scratch wound healing assay was
performed. Cells were grown to 90%+ confluency in 24-well tissue culture plates
with ibidi inserts for wound closure assay (Culture-Inserts for self-insertion
Catalog# 80209). Cells were plated and wounds imaged in triplicate. Images of
wounds were taken every 4 hours for a 24-hour period after removal of insert
9

with a bright field microscope with phase contrast. Images were assessed with
imageJ to measure size of wound. Six measurements of the wound width were
taken for each image at each four-hour time point and averaged per well. Wound
sizes were averaged for each cell line and compared through time lapse.
2.1.3 Anchorage Independent Growth
Soft agar assay was performed to assess the cell lines for ability to grow
and form colonies in an anchorage independent growth environment, an ability
which is a hallmark of aggressive cancer cells. Six-well plates were prepared with
a bottom layer of Noble agar and DMEM Media mix. The noble agar was
prepared as a 7% solution and was heated to mix agar powder with sterile
distilled water. DMEM powder was mixed with sterile distilled water to make a 2x
concentration of DMEM and was mixed with 20% FBS, 2% PS, 2% L-Glut, and
2% anti-anti. The 2x DMEM mixture and the 7% agar were mixed together at a
one to one ratio at 42oC and 1mL of the mixture was added into each well of all
6-well plates to be used. This layer is allowed to cool at 37 oC for at least one
hour. Final concentration of this bottom agar layer was 1x DMEM mixture and
3.5% agar. The next agar layer was then prepared using 3% noble agar heated
to mix powder with water. DMEM was prepared by diluting the 2x DMEM to 1x
and adding 10% FBS, 1% PS, 1% L-Glut, and 1% anti-anti. Cells were then
added at a concentration of 100,000 cells per milliliter in to the 1x DMEM mixture.
The 3% agar was allowed to cool to 42oC then mixed with the DMEM cell mixture
at a one to one ratio. 1mL of this mixture was then added on top of the first agar
10

layer in each well of the 6-well plates. The final concentrations in this layer were
1.5% agar, 0.5x DMEM mixture, and 50,000 cells per well. This layer was
allowed to cool at 37oC for at least one hour. After cooling a 0.5 mL feeding layer
was added to the top of the agar wells, the feeding layer consists of 1x DMEM,
10% FBS, 1%PS, 1% L-Glut, and 1% anti-anti. Cells were allowed to grow for 30
days and were fed at least twice per week with 0.5 mL feeding media per well.
Wells were stained with 0.01% crystal violet at 37 oC for 30 minutes and washed
with water until colonies could be seen and counted with the naked eye.
2.2 Xenograft – In vivo Assays

2.2.1 Preparation of Ovarian Cancer Cells

To allow in vivo visualization, cells were virally transduced with a
luciferase/GFP expression vector. Luciferin was added to cells or mice to allow
bioluminescence imaging; plasmid design shown in Figure 4. The cells were then
selected for and isolated by their fluorescence through the use of a FACSAria
flow cytometry cell sorter at the Genomics Core at the University of California
Riverside.
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Figure 5.. Luciferase plasmid construct.

2.2.2 Lentiviral Knockdown
Snail or control (scrambled) knockdown (KD) cells were utilized for
xenograft experiments

22

. Stable cell lines with pLK0.1-based
based small hairpin (sh)

RNA vectors were created by selection with puromycin. Cells were then cultured
in order to obtain the number of cells to be injected during surgery.
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2.2.3 Surgical Orthotopic Injection of Ovarian Cancer Cells
The ovarian cancer cells were prepared at 2.5 x10 5 cells per mouse in
phosphate-buffered saline (PBS) and ovarian bursa injections were done as
follows: before injection the cells were mixed with equal parts Matrigel from
Corning (catalog #354248). The mouse was anesthetized and the right ovarian
bursa was exposed through a dorsal incision. The cells were injected into the
ovarian bursa, the bursa was replaced in the mouse, and the incision was closed.
The mice were monitored for post-surgical recovery twice daily for three days,
then daily for four days.
2.2.4 Live Mouse Imaging
Mice were imaged 1-2x weekly with an IVIS Lumina Series III In Vivo
imaging system by PerkinElmer. Mice were anesthetized and given an
intraperitoneal injection of luciferin. Images of mice were analyzed using Living
Image In Vivo Imaging Software to determine size of primary and metastatic
tumors. At the time of imaging weights and girth of mice were recorded.
2.2.5 Tumor Harvest
Mice were euthanized according to a Loma Linda University Institutional
Animal Care and Use Committee approved protocol. Necropsy was then
performed, removal of tumors from mouse with pictures and notes on location of
tumor were done. Tumors are weighed and then processed for further
assessment. A portion of each primary tumor or metastasis was sent to histology
for further analysis. The remaining tumor was finely chopped and a portion was
13

saved for RNA analysis through qPCR. The remainder of the tumor is then
broken down to the cellular level by washing the chopped tumor through a basket
filter and cells were collected and saved for flow cytometry and western blot
analysis.
2.3 Molecular Biology

2.3.1 RNA Extraction and qPCR

RNA extraction was performed using TRIzol Reagent (catalog #15596)

from Life Technologies. CDNA preparation was performed in MulitiGene OptiMax
by Labnet International, Inc. using Maxima First Strand cDNA Synthesis Kit
(catalog #K1671) by Thermo Scientific. Quantitative PCR was performed using
KAPA SYBR FAST qPCR Kit Master Mix (2x) Universal (catalog #KK4600) in a
Stratagene Mx3005P by Agilent Technologies. Primers used for cancer stem cell
analysis included human Nanog, Lin28, and Oct4. Primers used for epithelial to
mesenchymal phenotype included human E-cadherin, N-cadherin, and Snail.
Activinβ was used as a control for all primers. All primers were purchased from
Integrated DNA Technologies (IDT).
Table 1. Primer sequences used for qPCR.
Primer for Forward
Nanog

5'-CAAAGGCAAACAACCCACTT-3'

Oct4

5'-AAGCGATCAAGCAGCGACTAT-3'

Lin28

Reverse

5'-TCTGCTGGAGGCTGAGGTAT-3'

5'-GAGCATGCAGAAGCGCAGATCAAA-3' 5'-TATGGCTGATGCTCTGGCAGAAGT-3'
GGAAAGGGACCGAGGAGTACA-3'

E-cadherin 5'-TGCCCAGAAAATGAAAAAGG-3'

5'-GTGTATGTGGCAATGCGTTC-3'

N-cadherin 5'-GAGGAGTCAGTGAAGGAGTCA-3'
Snail
ActB

5'-GGGAAGTTGATTGGAGGGATG-3'

5'-CACTATGCCGCGCTCTTTC-3'

5'-GGTCGTAGGGCTGCTGGAA-3'

5'-TGAAGTGTGACGTGGACATC-3'

5'-GGAGGAGCAATGATCTTGAT-3'
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2.3.2 Flow Cytometry
Flow cytometry analysis was performed on cell line and mouse xenograft
samples. Cells were preserved in FACS Stain made of PBS with 1% FBS, 0.1%
Sodium Azide, and 2mM EDTA. Cells were stained in FACS stain with antibodies
at 4oC for 15 minutes, washed, and then fixed in FACS Fix, FACS Stain + 1%
PFA. UltraComp eBeads (catalog #01-2222) from affymetrix eBioscience were
used for compensation and were stained as single stain samples. Flow cytometry
was performed on MACSQuant Analyzer 10 by Miltenyi Biotec and analysis of
data was performed using FlowJo Version 10 from FLOWJo, LLC. Antibodies for
CD44, CD117 (c-Kit), and CD133, as well as “Aldefluor” a fluorescent reagent
system to detect aldehyde dehydrogenase 1 (ALDH1) were used to analyze
cancer stem cell makeup of the cell population. Antibodies for E-cadherin
(CD324) and N-cadherin (CD325) were used to analyze epithelial or
mesenchymal makeup of the cell population. Populations were gated with the
use of isotypes: each antibody channel was gated separately against forward
scatter then overlaid to determine populations positive for multiple antibodies as
shown in Figure 6.
Table 2. Antibodies used for flow cytometry.
Antibody/Kit
CD44
CD117
CD133
E-cadherin
N-cadherin
Aldeflour

Source
Mouse
Mouse
Mouse
Rat
Mouse
N/A

Clone
G44-26
A3C6E2
293C3
67A4
8C11
N/A

Manufacture
BD Biosciences
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
BD Biosciences
Stemcell Technologies

15

Catalog #
561292
130-099-326
130-090-854
130-099-141
563435
01700

Isotype
IgG2b,k
IgG1, k
IgG2b,k
IgG1
IgG1, k
Control in kit

Catalog #
560374
130-100-098
400319
130-098-563
550795

Figure 6.. Flow cytometry gating with the aid of isotype stained population.
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CHAPTER THREE
RESULTS
3.1 Aim 1: The Characterization of Epithelial Ovarian Cancer
Cell Lines for Epithelial Mesenchymal Transition status,
Cancer Stem Cell makeup, and metastatic potential

3.1.1 Epithelial Mesenchymal Transition Status and Cancer Stem
Cell Makeup of Epithelial Ovarian Cancer Cell Lines

EOC cell lines were analyzed based on appearance in phase contrast
bright field microscopy to determine general morphology and ability of cell lines
to form colony like structures (Figure 7). It was determined by appearance and
ability to form colony like structures that Kuramochi and OVSAHO have the most
epithelial morphology. It was determined SKOV3 and COV318 have a more
mesenchymal morphology. Based on their less epithelial structure but retention
of the colony forming ability A2780-luc and OVCAR8 appear to be somewhat
mesenchymal and somewhat epithelial.
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A2780-luc

SKOV3

OVCAR8

Kuramochi

OVSAHO

COV318

Figure 7. Phase contrast bright field microscopy images of epithelial ovarian
cancer cell lines.

With the use of qPCR of Snail, N-cadherin, and E-cadherin the cell lines
can be identified as having epithelial or mesenchymal mRNA expression. If the
E-cadherin expression is high and the N-cadherin is low the cells can be
identified as more epithelial than mesenchymal. Therefore, OVCAR8, and
OVSAHO can be identified as having epithelial mRNA expression and COV318
and SKOV3 can be identified as having mesenchymal mRNA expression (Figure
8a). Flow cytometry showed the protein level of E-cadherin was high in all the
EOC cell lines (Figure 8b). The cell lines were split into two groups based on
having larger N-cadherin populations: COV318, SKOV3 and OVCAR8 were all
18

designated as mesenchymal-like, and having a smaller N-cadherin population
A2780-luc and Kuramochi were classified as epithelial. It was also observed that

b)

N-cad+/E-cad+

ovcar8

ovsaho

ovcar8

skov3

0.01

cov318

0.1

E-cad+

skov3

1

N-cad+

cov318

Percent of Intact Cells

10

100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%

kuramochi

E-cad

a2780 luc

N-cad

100

kuramochi

a)

Snail

1000

a2780-luc

Expression relative to Fibroblast

many cells were double positive for E-cadherin and N-cadherin.

Figure 8. Epithelial mesenchymal transition markers in epithelial ovarian cancer
cell lines. a) qPCR for Snail, N-cadherin, and E-cadherin expression in EOC cell
lines. b) Flow cytometry percent positive cells for E-cadherin, N-cadherin, and Eand N-cadherin double positive cells.

The CSC and pluripotency marker Lin28 is detectable in all cell lines
except COV318 and the marker Nanog has detectable expression in COV318
and OVSAHO (Figure 9a); Oct4 expression was low in all cells. The high Lin28
levels in comparison to fibroblasts could be explained by the lower let-7 miRNA
levels observed in the cell lines (Figure 9b). CD44 positive populations range
from 6 to 95 percent of the total intact EOC cells with SKOV3 showing the
highest activity. CD117 positive populations range from 31 to 79 percent of the
total intact EOC cells with Kuramochi showing the highest activity. CD133
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positive populations range from 10 to 93 percent with a2780-luc showing the
highest activity (Figure 9c). We classified cells as CSCs if they were positive for
more than one CSC marker. Shown are the triple CSC marker positive and
therefore true cancer stem cells. These CSC populations range from 2 to 70
percent of the total intact cell population of the EOC cell lines (Figure 9d). A2780luc, COV318, and Kuramochi are all positive for aldehyde dehydrogenase activity
shown by Aldeflour positive populations, ALDH1 activity could not be determined
in the OVCAR8 because they were GFP positive and the Aldeflour is detected in
the GFP channel (Figure 9e).
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Figure 9. Cancer stem cell markers in epithelial ovarian cancer cell lines. a)
qPCR for Lin28, Nanog and Oct4 expression in EOC cell lines. b) QPCR of Let-7
family members. c) Flow cytometry percent positive cells for CD44, CD117, and
CD133. d) CD44, CD117, CD133 triple positive population of EOC cell lines. e)
Aldeflour positive populations of EOC cell lines.

In the cancer stem cell population, it was observed that cells in the triple
positive CD44/CD117/CD133 population were also double positive for N21

cadherin and E-cadherin
cadherin (Figure 10a). This triple positive CSC population is 85 to
100 percent double positive for N
N-cadherin and E-cadherin
cadherin (Figure10b). The
CD44, CD117, CD133,
33, N
N-cadherin, and E-cadherin
cadherin positive population makes up
a small portion of the intact cells for most of the cell lines, ranging from 2 to 14
percent, but SKOV3 stands out as having a high population of these cells at 60
percent (Figure 10c).
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CSCs flow cytometry plot for N-cadherin
cadherin and Ecadherin. b) Triple positive CSCs are 85 to 99% double positive for N-cadherin
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and E-cadherin. c) CSC and N-cadherin/E-cadherin double positive cells out of
entire intact population.

3.1.2 Metastatic Potential of Epithelial Ovarian Cancer Cell Lines
It was observed that only two cell lines show high activity in the scratch
assay, defined as higher than normal fibroblasts, showing they have high motility:
SKOV3, and OVCAR8 (Figure 11a). Scratch assay could not be performed on
Kuramochi, OVSAHO or COV318 as when the scratch is performed on confluent
plates the cells remove as a sheet instead of leaving the wound behind. In the
soft agar assay showing anchorage independent growth the A2780-luc, OVCAR8
and SKOV3 all showed high ability to grow independent colonies (Figure 11b).
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3.2 Aim 2
2: The Effect of Snail Knockdown on Epithelial
thelial
Mesenchymal Transition status, Cancer Stem Cell
makeup, and metastatic potential of an Epithelial
Ovarian Cancer Cell Line OVCAR8
3.2.1 Confirmation of Snail Knockdown
Snail knockdown was done virally and was tested with qPCR to confirm
Snail was knocked down (Figure 12a). With shSnail, as the pluripotency marker
24

Nanog decreases let-7
7 miRNA levels inc
increase (Figure 12a). This
his decrease in
Nanog and increase in let
let-7 shows the shSnail exhibits less stemness than
shControl. OVCAR8 shControl and shSnail showed no noticeable morphological
changes (Figure 12b)..
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Figure 12.. Confirmation of Snail knockdown and let-7
7 expression in shSnail. a)
qPCR of Snail, Nanog, E
E-cadherin, and multiple let-7 miRNAs. b) Phase contrast
bright field microscopy images of shControl and shSnail OVCAR8
AR8 cell lines.

25

3.2.2 Epithelial Mesenchymal Transition Status and Cancer Stem
Cell Makeup in Snail Knockdown Model
The relative level of N-cadherin mRNA expression did not decrease in
shSnail as expected; instead the expression increased (Figure 13a). shSnail did
however decrease E-cadherin expression. The pathways leading to the mRNA
expression of these two cadherins may not behave in cancerous cells as they do
in normal cells. On a protein level, as percent of the total intact cell population,
only very minor changes were detected in the shSnail OVCAR8 as compared to
shControl. E-cadherin activity change was very low, 1.1x shControl. N-cadherin
positive cells decreased only slightly to 0.98x shControl. N-cadherin/E-cadherin
double positive cell populations did slightly increase with shSnail by 1.08x
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3
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shControl (Figure 13b).
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Figure 13. Epithelial mesenchymal transition markers in Snail knockdown model.
a) qPCR for Snail, N-cadherin, and E-cadherin expression in shSnail EOC. b)
Flow cytometry percent positive cells for E-cadherin, N-cadherin, and E-and Ncadherin double positive cells in shSnail EOC.
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In OVCAR8 shSnail pluripotency mRNA markers Lin28, Nanog, and Oct4
all decreased (Figure 14a). CD133 positive cell population was extremely low in
both shControl and shSnail, dramatically lower than the levels found in parental
OVCAR8. The population of CD133 positive cells went from about 11% in the
parental OVCAR8 (Figure 9c) to almost 0% in the virally treated cells
(Figure14b). Cancer stem cell marker CD44 positive population was decreased
by over half in OVCAR8 shSnail (Figure 14c). Percentage of CD117 positive cell
populations increased in OVCAR8 shSnail (Figure 14b). There were no triple
positive CSC populations of cells detected in the shSnail model due to the loss of
CD133.
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Figure 14. Cancer stem cell markers in Snail knockdown model. a) qPCR for
Lin28, Nanog, and Oct4 expression in shSnail EOC. b) Flow cytometry CD133
activity in the virally transduced lines compared to the parental line. c) Flow
cytometry percent positive cells for CD44, and CD117 in shSnail EOC
normalized to shControl.

3.2.3 Metastatic Potential in Snail Knockdown Model
In OVCAR8, shSnail did not have a significant change in wound healing
ability as compared to shControl. All virally treated cell lines were less able to
colonize in anchorage independent growth compared to non virally treated cells.
None of the virally treated pairs showed a significant difference in growth
between the shControl and shSnail.
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Figure 15. Metastatic potential assays of Snail knockdown epithelial ovarian
cancer. a) Scratch assay percentage wound healing over time. b) Soft agar
assay colonies formed by a variety of shSnail EOC cells.

3.2.4 Orthotopic Xenograft of Snail Knockdown OVCAR8
Snail knockdown showed a trend of a decrease in primary and metastatic
tumor burden when compared to control in weight of tumor at harvest time
(Figure 16a). Live imaging of the mice allowed the analysis of tumor growth in the
live mice (Figure 16b). The analysis of the weekly mouse images did not show a
difference in the primary growth of tumors with shSnail. This analysis did show a
decrease in metastatic growth with a significant decrease in growth at day 43.
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CHAPTER FOUR
DISCUSSION
Epithelial Mesenchymal Transition and Cancer Stem Cells in
Epithelial Ovarian Cancer

During a normal EMT event a cadherin switch from N-cadherin to Ecadherin occurs. E-cadherin transcription is down regulated and the competition
between E- and N-cadherin for p120-catenin will increase N-cadherin activity and
cause the endocytosis and degradation of E-cadherin25. Based on the high
presence of N-cadherin/E-cadherin double positive cells in the EOC cell lines
(Figure 8b) there could be changes in signaling leading to E-cadherin
degradation with EMT events in cancer. Misregulation of the balance between
p120 complexes at apical and basolateral cell-cell contact areas 26 could
contribute to a faulty cadherin switch. The hybrid epithelial/mesenchymal state
represents aberrant EMT and has been observed in cancer 27. This would explain
why the cell lines in this experiment showed a continuum of epithelial to
mesenchymal behavior rather than remaining on one end of the spectrum or the
other.
EOC lines have been evaluated as to their genomic similarity to patient
samples28,

growth

characteristics,

xenograft-forming

ability29,

genomic

alterations, expression of markers, drug resistance, and in vitro behavior 30. A few
cell lines (OVSAHO, Kuramochi, COV318, OVCAR8) stood out as good
examples of EOC based on previously published data 28-30, therefore SKOV3 and
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A2780 lines were eliminated from use after the initial characterization was
complete. Kuramochi and OVSAHO stood out as the most epithelial lines when
all data was combined and COV318 stood out as most mesenchymal. Notably,
OVSAHO and Kuramochi were previously shown to poorly form xenografts 30.
OVCAR8 was shown to reliably and quickly form xenografts and ascites 29. All
three of these lines also contained CSCs at detectable but variable levels.
OVCAR8 stood out as having a more hybrid phenotype between epithelial and
mesenchymal states, a low to moderate level of CSCs, and high activity in
metastatic potential assays; therefore, this line was chosen for the Snail
knockdown model. Snail was detectable at levels above that in the mesenchymal
fibroblasts used for normalization in all lines. Let-7 expression was observed to
be lower than fibroblasts for most of the family members assessed. Notably, lines
with lowest let-7 expression were observed to express higher levels of Lin28.
This is consistent with decreased let-7 as a marker for CSC, but we have not
tested whether the decreased let-7 levels are cause or effect of Lin28
expression.
EOC cell populations positive for CD44, CD117, and CD133 were
classified as true cancer stem cells. Functional tests to prove this assertion will
be done in the future. Cells positive for each of these markers individually have
been classified as CSCs in other publications 13,21,31 however individually or in
certain pairings these markers can be detected in progenitor cancer cells and not
only in CSC13. We show that these triple positive cancer stem cells are the same
32

cells which are double positive for E-cadherin and N-cadherin. Therefore, the
process that causes a cell to become a CSC may be the pathway both turning Ncadherin activity on and causing a loss of E-cadherin degradation that normally
takes place in an EMT event. Identifying this CSC EMT positive subset of cells
may be an important diagnostic and prognostic tool in the clinic. The ability to
identify this subset could also be helpful in identifying best possible treatment
plans for patients.
Epithelial Mesenchymal Transition and Cancer Stem Cells in
Snail Knockdown Model of Epithelial Ovarian Cancer

In the shSnail model on a mRNA level the N-cadherin expression did not
decrease, and the E-cadherin expression did not increase as expected. Instead
the N-cadherin expression increased and the E-cadherin expression decreased
(Figure 13a). On a protein level the percentage of cells positive for N-cadherin
did decrease very slightly and the percentage of E-cadherin positive cells did
slightly increase (Figure 13b). shSnail did decrease pluripotency mRNA
expression for Lin28, Nanog, and Oct4. shSnail did not show a consistent loss of
CSC surface markers; the CD44 positive population decreased as the CD117
population increased compared with shControl. CD133 activity decreased to
almost nothing in both the virally delivered shControl and shSnail. Therefore,
there were no triple positive CSC populations in the viral shRNA model. Taken
together, we conclude that CD133, which has no published known function, may
be involved in or is sensitive to the viral response of the cell in some way.
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In the metastatic potential for the viral shRNA cell lines we did not
determine there to be a difference in the metastatic potential between the
shControl and the shSnail. In the scratch assay if there was a difference in the
motility between shControl and shSnail we may not have been able to determine
a difference due to differing proliferation rates of the cells lines. In both the cell
line and viral shRNA line characterizations the motility in the scratch assay may
have in part been due to the proliferation of the cells; for this reason, in the future
we can inhibit the proliferation of cells with the use of mitomycin c treatment
during the scratch assay.
In a xenograft model shSnail shows a trend of decreasing tumor burden
for both primary and metastatic tumor burden as measured by weight of tumor
burden at final harvest. A statistically significant difference was seen in the
growth of the metastatic tumors by in vivo imaging analysis of live mice with
metastatic growth in shSnail at day 43, as compared to shControl. Although
Snail knockdown did not show all the anticipated responses in vitro Snail may still
be a viable target in decreasing metastasis in cancer.
In the future we plan to use a different model to inhibit Snail activity in
ovarian cancer, small inhibitory RNA (siRNA). In this study it became clear that
the viral treatment of the ovarian cancer cells had some effect on the CSC and
EMT makeup of the cell populations when comparing Figures 8 and 9 to raw
population numbers in the sh model. The findings of the sh model are still valid
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as the shSnail is compared to a shControl that was treated with the same viral
treatment. This viral response would be avoided with the use of a siRNA.
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